全文获取类型
收费全文 | 237篇 |
免费 | 30篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 24篇 |
口腔科学 | 1篇 |
临床医学 | 10篇 |
内科学 | 9篇 |
皮肤病学 | 137篇 |
神经病学 | 1篇 |
外科学 | 4篇 |
综合类 | 3篇 |
预防医学 | 28篇 |
眼科学 | 25篇 |
药学 | 20篇 |
中国医学 | 1篇 |
肿瘤学 | 3篇 |
出版年
2022年 | 3篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2014年 | 2篇 |
2013年 | 2篇 |
2012年 | 6篇 |
2011年 | 2篇 |
2010年 | 2篇 |
2009年 | 3篇 |
2008年 | 8篇 |
2007年 | 9篇 |
2006年 | 3篇 |
2005年 | 3篇 |
2004年 | 11篇 |
2003年 | 9篇 |
2002年 | 9篇 |
2001年 | 7篇 |
2000年 | 17篇 |
1999年 | 8篇 |
1998年 | 5篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 8篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 11篇 |
1989年 | 10篇 |
1988年 | 9篇 |
1987年 | 5篇 |
1986年 | 9篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1967年 | 2篇 |
1966年 | 2篇 |
1965年 | 4篇 |
1964年 | 4篇 |
1962年 | 2篇 |
1945年 | 7篇 |
1943年 | 2篇 |
1934年 | 3篇 |
1933年 | 2篇 |
1930年 | 1篇 |
排序方式: 共有267条查询结果,搜索用时 0 毫秒
101.
Contact dermatitis 总被引:1,自引:1,他引:0
Klaus E. Andersen Claude Benezra Desmond Burrows Jose Camarasa An Dooms-Goossens Georges Ducombs Peter Frosch Jean-Marie Lachapelle Arto Lahti Torkil Menné Richard Rycroft Rik Scheper Ian White John Wilkinson 《Contact dermatitis》1987,16(2):55-78
In recent years, there has been a dramatic rise in our understanding of contact dermatitis. This paper is a review of our knowledge of the mechanisms involved in contact dermatitis and related phenomena, the investigation of these events and the emergence of significant new allergens during the last 5 years. 相似文献
102.
103.
104.
Medicament contact dermatitis in patients with chronic inflammatory ear disease 总被引:1,自引:0,他引:1 下载免费PDF全文
R C Holmes A N Johns J D Wilkinson M M Black R J Rycroft 《Journal of the Royal Society of Medicine》1982,75(1):27-30
Patch testing of 40 patients with chronic inflammatory ear disease demonstrated medicament allergic contact dermatitis in 35%. The most frequent sensitizers were neomycin, framycetin, clioquinol and gentamicin. Although allergic contact dermatitis to dewaxing ear drops was unusual, irritant reactions were common. 相似文献
105.
Regulation of single NMDA receptor channel activity by alpha-actinin and calmodulin in rat hippocampal granule cells 总被引:3,自引:2,他引:1
The NMDA receptor is modulated by changes in the intracellular calcium concentration, through activation of various intracellular calcium-dependent proteins. We have investigated regulation of single NMDA receptor channel activity by the calcium-sensing proteins alpha-actinin and calmodulin. Both of these proteins bind to the NMDA receptor NR1 subunit C-terminus at the C0 region where they compete for occupation of the C0 site and contribute to calcium-dependent inactivation of NMDA receptor-mediated whole-cell currents. Calmodulin has also been shown to bind to the neighbouring C1 region where it has been shown to reduce single channel open time. To investigate regulation of single NMDA channel activity by alpha-actinin and calmodulin, we selected concentrations of these two proteins that would result in maximal binding to the C0 region and/or the C1 region in the case of calmodulin. Alpha-actinin binding was found to predominantly decrease single channel shut time, resulting in an increased open probability ( P open ), whereas calmodulin binding reduced single channel mean open time, resulting in an overall reduction in P open . The physiological implications of these findings are discussed. 相似文献
106.
107.
108.
Isaksson M Andersen KE Brandão FM Bruynzeel DP Bruze M Camarasa JG Diepgen T Ducombs G Frosch PJ Goossens A Lahti A Menné T Rycroft RJ Seidenari S Shaw S Tosti A Wahlberg J White IR Wilkinson JD 《Contact dermatitis》2000,42(1):27-35
This study investigated whether a corticosteroid mix containing tixocortol pivalate, budesonide, and hydrocortisone-17-butyrate could detect contact allergy to corticosteroids. 2 corticosteroid mixes, 1 with a high (mix I) and 1 with a low (mix II) concentration and the 3 individual constituents, each at 2 concentrations, were inserted into the standard series of 16 participating clinics. Tests were read on day (D) 3 or 4. 5432 patients were tested, and 110 (2.0%) had positive reactions to at least 1 of the 8 test preparations. Of the 8 preparations, mix I identified most allergic patients, followed by mix II, budesonide 0.10%, budesonide 0.002%, and tixocortol pivalate, both concentrations (1.0 and 0.10%) tracing the same number. With the mixes, 53.2-59.6% of tixocortol pivalate allergy was missed. 47 patients were allergic to either concentration of tixocortol pivalate, 25% of these only to 1.0% and another 25% only to 0.10%. Testing with mix I and tixocortol pivalate 0.10% picked up 98/110, testing with tixocortol pivalate 1.0% and 0.10% and budesonide 0.10% picked up 105/110. 3379 patients were read on both D3 or D4 as well as on D7. Without a late reading (D7), up to 30% of contact allergy to corticosteroid markers was missed. 相似文献
109.
Tanaka S Matsumoto Y Dlova N Ostlere LS Goldsmith PC Rycroft RJ Basketter DA White IR Banerjee P McFadden JP 《Contact dermatitis》2004,51(1):20-21
We have studied patients who have positive-patch test reactions to fragrance-allergic screening substances fragrance mix (FM) or Myroxylon pereirae resin (balsam of Peru) for immediate contact reactions to the standard FM, the constituents of the FM and Myroxylon pereirae resin. In the fragrance-positive subjects (n = 60), there were positive immediate contact reactions to Myroxylon pereirae resin in 56.6% and to FM in 11.6%. In a control group (n = 50) of eczematous, patch test-negative patients there were positive immediate reactions to Myroxylon pereirae resin in 58.0% subjects and to FM in 12.0%. The absence of a significant difference between the fragrance-allergic group and control group is in keeping with a non-immunological basis for the majority of the immediate reactions seen. 相似文献
110.
P. J. Frosch Beate Pilz K. E. Andersen D. Burrows J. G. Camarasa A. Dooms-Goossens G. Ducombs T. Fuchs M. Hannusksela J. M. Lachapelle A. Lahti H. I. Maibach T. Menné R. J. G. Rycroft S. Shaw J. E. Wahlberg I. R. White J. D. Wilkinson 《Contact dermatitis》1995,33(5):333-342
The objective of this study was to determine the frequency of reactivity to a series of commonly fragrances in dermatological patients. A total of 48 fragrances (FF) were chosen, based on the publication of Fenn in 1989 in which the lop 25 constituents of 3 types (1. perfumes, 2. household products, 3. soaps) of 400 commercial products on the US market had been determined. In a pilot study on a total of 1069 patients in 11 centres, the appropriate test concentration and vehicle were examined. For most fragrances, 1% and 5% were chosen, and petrolatum proved to be the best vehicle in comparison to isopropyl myristate and diethyl phthalate. In the main study, a set of 5 to 10 fragrances at 2 concentrations was patch tested in each centre on a minimum of 100 consecutive patients seen in the patch test clinic. These patients were also patch tested to a standard series with the 8% fragrance mix (FM) and its 8 constituents. In patients with a positive reaction to any of the 48 FF, a careful history with regard to past or present reactions to perfumed products was taken. A total of 1323 patients were tested in 11 centres. The 8% FM was positive in 89 patients (8.3% of 1072 patients). Allergic reactions to the constituents were most frequent to oak moss (24), isoeugenol (20), eugenol (13), cinnamic aldehyde (10) and geraniol (8). Reactions read as allergic on day 3/4 were observed only 10 × to 7 materials of the new series (Iso L: Super® (2), Lyral® (3), Cyclacet® (1), DMBCA (1), Vertofix® (1), citronellol (1) and amyl salicylate (1)). The remaining 41 fragrances were negative. 28 irritant or doubtful reactions on day 3/4 were observed to a total of 19 FF materials (more than 1 reaction: 5% citronellol (2), 1%amyl salicylate (2), 1%isononyl acetate (3), 0.1% musk xylol (2). 1%citral (2), and 1% ionone beta (2)). Clinical relevance of positive reactions to any of the FF series was not proved in a single case. This included the 4 reactions in patients who were negative to the 8% FM. In conclusion, the top 25 fragrances commonly found in various products caused few reactions in dermatological patients and these few appeared to be clinically irrelevant, with the possible exeption of Lyral®. However, this data should be interpreted in the light of the relatively small number of patients tested (only 100 in most centres). 相似文献